[HTML][HTML] Evidence-based recommendations on categories for extent of resection in diffuse glioma
P Karschnia, MA Vogelbaum, M van den Bent… - European Journal of …, 2021 - Elsevier
Surgical resection represents the standard of care in diffuse glioma, and more extensive
tumour resection appears to be associated with favourable outcome. Up to now, terminology …
tumour resection appears to be associated with favourable outcome. Up to now, terminology …
Clinical management of diffuse low-grade gliomas
G Lombardi, V Barresi, A Castellano, E Tabouret… - Cancers, 2020 - mdpi.com
Simple Summary Diffuse low-grade gliomas (LGG) are relatively uncommon primary brain
cancers. In recent years, the molecular, diagnostic, and therapeutic approaches have …
cancers. In recent years, the molecular, diagnostic, and therapeutic approaches have …
Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas
M Rossi, L Gay, F Ambrogi, M Conti Nibali… - Neuro …, 2021 - academic.oup.com
Background Supratotal resection is advocated in lower-grade gliomas (LGGs) based on
theoretical advantages but with limited verification of functional risk and data on oncological …
theoretical advantages but with limited verification of functional risk and data on oncological …
High-throughput analysis of tissue microarrays using automated desorption electrospray ionization mass spectrometry
Tissue microarrays (TMAs) are commonly used for the rapid analysis of large numbers of
tissue samples, often in morphological assessments but increasingly in spectroscopic …
tissue samples, often in morphological assessments but increasingly in spectroscopic …
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
Background PET with radiolabeled amino acids is used in the preoperative evaluation of
patients with glial neoplasms. This study aimed to assess the role of [11C] methionine (MET) …
patients with glial neoplasms. This study aimed to assess the role of [11C] methionine (MET) …
The concept of «peritumoral zone» in diffuse low-grade gliomas: oncological and functional implications for a connectome-guided therapeutic attitude
M Silva, C Vivancos, H Duffau - Brain Sciences, 2022 - mdpi.com
Diffuse low-grade gliomas (DLGGs) are heterogeneous and poorly circumscribed
neoplasms with isolated tumor cells that extend beyond the margins of the lesion depicted …
neoplasms with isolated tumor cells that extend beyond the margins of the lesion depicted …
The ability to return to work: a patient-centered outcome parameter following glioma surgery
C Senft, M Behrens, I Lortz, K Wenger, K Filipski… - Journal of neuro …, 2020 - Springer
Background With refinements in diagnosis and therapy of gliomas, the importance of
survival time as the sole outcome parameter has decreased, and patient-centered outcome …
survival time as the sole outcome parameter has decreased, and patient-centered outcome …
ALYREF (Aly/REF export factor): A potential biomarker for predicting cancer occurrence and therapeutic efficacy
Y Zhao, C Xing, H Peng - Life Sciences, 2023 - Elsevier
Methylcytosine (m5C) methylation is present in almost all types of RNA as an essential
epigenetic modification. It is dynamically modulated by its associated enzymes, including …
epigenetic modification. It is dynamically modulated by its associated enzymes, including …
Cortical mapping in glioma surgery: correlation of fMRI and direct electrical stimulation with Human Connectome Project parcellations
C Bennett, M González, G Tapia, R Riveros… - Neurosurgical …, 2022 - thejns.org
OBJECTIVE Noninvasive brain mapping with functional MRI (fMRI) and mapping with direct
electrical stimulation (DES) are important tools in glioma surgery, but the evidence is …
electrical stimulation (DES) are important tools in glioma surgery, but the evidence is …
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics
KK Yeo, S Alexandrescu, JA Cotter… - Neuro …, 2023 - academic.oup.com
Background The incidence and biology of IDH1/2 mutations in pediatric gliomas are unclear.
Notably, current treatment approaches by pediatric and adult providers vary significantly. We …
Notably, current treatment approaches by pediatric and adult providers vary significantly. We …